The US Federal Trade Commission filed suit Wednesday to block Edwards Lifesciences Corp. from acquiring medical device maker JenaValve Technology Inc.
In a complaint filed in Washington federal court, the FTC said the deal would hinder innovation for medical devices used to treat a serious heart condition known as aortic regurgitation, where blood pumped from the heart leaks back into the chamber
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.